A randomised double-blind phase II study of lamivudine (LAM) compared to lamivudine plus adefovir dipovoxil (ADV) for treatment naïve patients with chronic hepatitis B (CHB): Week 52 analysis
- 30 April 2003
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 38, 25-26
- https://doi.org/10.1016/s0168-8278(03)80485-3
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: